Matches in Wikidata for { <http://www.wikidata.org/entity/Q90586931> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q90586931 description "article scientifique publié en 2019" @default.
- Q90586931 description "artículu científicu espublizáu n'ochobre de 2019" @default.
- Q90586931 description "im Oktober 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90586931 description "scientific article published on 01 October 2019" @default.
- Q90586931 description "wetenschappelijk artikel" @default.
- Q90586931 description "наукова стаття, опублікована 1 жовтня 2019" @default.
- Q90586931 name "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 name "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 type Item @default.
- Q90586931 label "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 label "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 prefLabel "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 prefLabel "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 P1433 Q90586931-200FF3DD-84C6-4F01-B155-B46918C4CFA5 @default.
- Q90586931 P1476 Q90586931-6BD922C0-9D40-4C6A-A05E-9448B0EE308F @default.
- Q90586931 P2093 Q90586931-2C55E590-8A4F-4170-8F7F-EA823FF3ABA1 @default.
- Q90586931 P2093 Q90586931-7FD27F76-4548-452E-8813-F23E13F36918 @default.
- Q90586931 P2093 Q90586931-A244A840-6D2A-4038-BE5E-F5DC93A90271 @default.
- Q90586931 P2093 Q90586931-D454F155-9C46-4BFB-B360-5CCC14721410 @default.
- Q90586931 P2093 Q90586931-D66CD73C-CD9B-48B7-AFAF-C547E5972C8B @default.
- Q90586931 P2093 Q90586931-DFBE93E3-90DA-46FA-B2BD-505B3CE07012 @default.
- Q90586931 P2093 Q90586931-E165E3B9-605A-4B04-998C-0BB644910494 @default.
- Q90586931 P304 Q90586931-7F6E5A93-C007-4970-9E86-A81281A59B2E @default.
- Q90586931 P31 Q90586931-F187F588-D18C-4CF7-8583-15CA8B391BA9 @default.
- Q90586931 P356 Q90586931-B8A1EE2F-33B2-4C67-ABE3-569F2F6D2F59 @default.
- Q90586931 P433 Q90586931-121B7B4D-57E4-48A6-89E1-DE3D8110248D @default.
- Q90586931 P478 Q90586931-90018012-D848-4DD2-B001-E3A8673A146F @default.
- Q90586931 P577 Q90586931-95DDD5D8-2C83-48DD-A137-9D7509063176 @default.
- Q90586931 P698 Q90586931-D07756EB-2CC6-49F2-9886-18D7B4C52C5E @default.
- Q90586931 P356 MPA.0000000000001403 @default.
- Q90586931 P698 31593022 @default.
- Q90586931 P1433 Q15762014 @default.
- Q90586931 P1476 "Analysis of Real-World Treatment Patterns, Healthcare Resource Utilization, and Costs Between Octreotide and Lanreotide Among Patients With Neuroendocrine Tumors" @default.
- Q90586931 P2093 "Angie Lax" @default.
- Q90586931 P2093 "Beilei Cai" @default.
- Q90586931 P2093 "Dominique Lejeune" @default.
- Q90586931 P2093 "Lynn Huynh" @default.
- Q90586931 P2093 "Mei S Duh" @default.
- Q90586931 P2093 "Michelle K Kim" @default.
- Q90586931 P2093 "Mu Cheng" @default.
- Q90586931 P304 "1126-1135" @default.
- Q90586931 P31 Q13442814 @default.
- Q90586931 P356 "10.1097/MPA.0000000000001403" @default.
- Q90586931 P433 "9" @default.
- Q90586931 P478 "48" @default.
- Q90586931 P577 "2019-10-01T00:00:00Z" @default.
- Q90586931 P698 "31593022" @default.